Which vessels are involved in tuberculosis-associated vasculitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

TB Vasculitis: Vessel Involvement

Tuberculosis-associated vasculitis primarily affects small vessels (arterioles, capillaries, and venules), manifesting most commonly as cutaneous leukocytoclastic vasculitis with palpable purpura, particularly on the lower extremities. 1, 2

Primary Vessel Size Affected

Small vessel involvement is the hallmark of TB-associated vasculitis. The pathological process targets:

  • Arterioles, capillaries, and venules in the dermis and subcutaneous tissue 3, 1
  • Cutaneous manifestations present as leukocytoclastic vasculitis with palpable purpura, predominantly affecting the lower legs 1, 2
  • Histopathologic features include angiocentric segmental inflammation, fibrinoid necrosis, and neutrophilic infiltrate around vessel walls with erythrocyte extravasation 3

Clinical Presentation Pattern

The typical presentation follows a distinct pattern:

  • Palpable purpura on lower extremities is the classic finding, representing small vessel inflammation 1, 2
  • Systemic symptoms including fever, myalgia, and weight loss often accompany the cutaneous findings 1, 2
  • Subcutaneous nodules may occur, particularly in nodular vasculitis (erythema induratum of Bazin), which is characteristically associated with M. tuberculosis infection 4

Diagnostic Considerations

Tuberculosis should be considered as a causative agent when evaluating small vessel vasculitis, though it is a rare etiology. 1

Key diagnostic features include:

  • Skin biopsy demonstrating leukocytoclastic vasculitis with small vessel involvement 1, 2
  • Associated TB manifestations such as pulmonary involvement or tuberculous lymphadenitis 1, 2
  • Resolution with anti-tuberculosis treatment confirms the causal relationship 1, 2

Important Clinical Pitfall

Do not confuse TB-associated vasculitis with drug-induced vasculitis from anti-tuberculosis medications. Anti-TB drugs (particularly rifampicin and ethambutol) can themselves cause leukocytoclastic vasculitis, presenting identically with small vessel involvement and palpable purpura 5. The timing of symptom onset relative to treatment initiation is critical for distinguishing these entities.

Vessel Size Classification Context

While TB primarily affects small vessels, understanding the broader vasculitis classification is helpful:

  • Large vessels (aorta and major branches) are affected in giant cell arteritis and Takayasu arteritis 6
  • Medium vessels (main visceral arteries) are involved in polyarteritis nodosa 6
  • Small vessels (intraparenchymal vessels) are the target in TB-associated vasculitis, ANCA-associated vasculitis, and immune complex vasculitis 7, 8

References

Research

Cutaneous leukocytoclastic vasculitis accompanied by pulmonary tuberculosis.

Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia, 2008

Research

Small-vessel vasculitis.

Current rheumatology reports, 2007

Research

[Skin manifestations of different forms of vasculitis].

Zeitschrift fur Rheumatologie, 2013

Research

Cutaneous leukocytoclastic vasculitis associated with anti-tuberculosis drugs.

Pediatrics international : official journal of the Japan Pediatric Society, 2015

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Small Vessel Vasculitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Vasculitis Classification and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.